MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-20-0040021
Genip Formulations Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.44 Cr
▲ 512% YoY
Net profit · FY 2025
₹22.13 Lakh
Net margin 6.4%
EBITDA · FY 2025
₹60 Lakh
EBITDA margin 17.5%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
About Genip Formulations Private Limited
Data last updated:
Genip Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 April 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2022PTC161287. Its GSTIN is 02AAJCG6853B1ZW (Himachal Pradesh).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Gullapalli Srinivas and Gajawada Mahesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.44 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹22.13 Lakh (net margin 6.4%) and EBITDA of ₹60 Lakh (EBITDA margin 17.5%).
As per MCA filings, the company has open charges of ₹1 Cr on record.
Genip Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0040021). For more details, the company can be reached via its website genipformulations.com.
Company details
CIN U24290TG2022PTC161287
Registration Number 161287
Incorporation Date 05 April 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0040021
Key People
Gullapalli Srinivas Director Gajawada Mahesh Kumar Director Satyanarayana Dusari Director Recognitions & Rankings of Genip Formulations
Contact details
Genip Formulations Private Limited's registered office is in Hyderabad, Telangana. Its website is genipformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 6/1/A First Floor, Road No 14 Ida Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Genip Formulations Private Limited, buy the company report.
Comprehensive company report
Genip Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Genip Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Genip Formulations Private Limited, buy the company report.
Financials of Genip Formulations Private Limited
FY 2025 filings availableGenip Formulations Private Limited reported revenue of ₹3.44 Cr (up 512% YoY) for FY 2025.
Revenue · FY 2025
₹3.44 Cr ▲ 512%
Net profit · FY 2025
₹22.13 Lakh margin 6.4%
EBITDA · FY 2025
₹60 Lakh margin 17.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 512%
EBITDA CAGR growth
1 year
▲ 346%
Revenue rose 512% in the latest year. EBITDA rose 346% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹60 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹22.13 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 17.5% | ||
| Net Profit Margin | 6.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Genip Formulations Private Limited, buy the company report.
Board of directors of Genip Formulations Private Limited
Genip Formulations has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gullapalli Srinivas Also directs: Genip Pharmaceuticals Private Limited | Director | 05 Apr 2022 | 4 Years 6 Months | Current |
| Gajawada Mahesh Kumar Also directs: Genip Pharmaceuticals Private Limited | Director | 05 Apr 2022 | 4 Years 6 Months | Current |
| Satyanarayana Dusari Also directs: Genip Pharmaceuticals Private Limited | Director | 05 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Genip Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axelus Pharma Private Limited | ₹3.45 Cr (FY 2025) | 55.0% | Ankleshwer, Gujarat, India | |||
| Seamac Formulations Private Limited | ₹3.44 Cr (FY 2024) | 7.0% | Talwara, Punjab, India | |||
| Genip Formulations Private Limitedthis company | ₹3.44 Cr (FY 2025) | ₹22.13 Lakh | 6.4% | 512.0% | Hyderabad, Telangana, India | |
| Geluk Pharma Private Limited | ₹3.43 Cr (FY 2021) | 1457.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Genip Formulations Private Limited, buy the company report.
Auditor
Genip Formulations Private Limited is audited by L S REDDY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L S REDDY & CO | FY 2023 | 200697 |
Shareholding
The shareholding of Genip Formulations Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Genip Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Nov 2023 | 100814651 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Genip Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genip Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Genip Formulations Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Genip Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAJCG6853B1ZW | Himachal Pradesh | Active | 04 Jun 2022 |
To see the full GST registrations and return filing status of Genip Formulations Private Limited, buy the company report.
Recent activity
Genip Formulations Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Gajawada Mahesh Kumar was appointed as Director on 05 Apr 2022.
AGM
Genip Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genip Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100814651 was registered on 20 Nov 2023.
Appointed
Gajawada Mahesh Kumar was appointed as Director.
Appointed
Gullapalli Srinivas was appointed as Director.
Appointed
Satyanarayana Dusari was appointed as Director.
Incorporation
05 Apr 2022
Genip Formulations Private Limited was registered on 05 Apr 2022 with Roc Hyderabad & aged 4 years 6 months as per MCA records.
Frequently asked questions
Genip Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 April 2022 (4+ years old) and is registered under CIN U24290TG2022PTC161287.
Genip Formulations has 3 current directors:
- Gullapalli Srinivas - Director
- Gajawada Mahesh Kumar - Director
- Satyanarayana Dusari - Director
The latest financial statements of Genip Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Genip Formulations is 02AAJCG6853B1ZW, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Genip Formulations is U24290TG2022PTC161287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genip Formulations was incorporated on 05 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Genip Formulations by revenue are Axelus Pharma Private Limited, Seamac Formulations Private Limited, Geluk Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gajawada Mahesh Kumar was appointed as Director on 05 Apr 2022. Gullapalli Srinivas was appointed as Director on 05 Apr 2022. Satyanarayana Dusari was appointed as Director on 05 Apr 2022.
Yes, Genip Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0040021).
Genip Formulations can be reached through the website genipformulations.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Genip Formulations is at Plot No 61A First Floor, Road No 14 Ida Nacharam, Hyderabad, Telangana, India – 500076.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages